Delivery Order SPE2DB22D1106-SPE2DB25FEYW4
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,451.13 for Ciprofloxacin-Dexamethasone otic suspension (7.5mL) on July 23, 2025, with completion scheduled for July 24, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $2,911.68 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a pharmaceutical product used for ear infections. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of July 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this delivery order, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 26, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic-corticosteroid medication used to treat ear infections. This firm fixed price delivery order has a ceiling value of $3,138.24 and is scheduled for completion by July 28, 2025. The award was made competitively without a set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,542.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with an ultimate completion date of July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made on a non-set-aside,...
- The Defense Logistics Agency awarded a delivery order valued at $11,058.41 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) under a firm fixed-price contract. The award was made on July 25, 2025, with an ultimate completion date of July 28, 2025, and represents a competitive award with no set-aside designation. Performance will be completed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,401.76 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5 mL) on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract employs firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,647.96 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic and anti-inflammatory medication used to treat ear infections. The contract, executed on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. Performance will be conducted at AmerisourceBergen's facility...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-seven thousand seven hundred thirty dollars and ninety-five cents ($27,730.95) to Amerisourcebergen Drug Corporation for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ml. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania under a September 11-12, 2023 period of performance. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5 mL. The contract, valued at $1,494.82, has a firm fixed price and an ultimate completion date of September 12, 2023. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- The Defense Logistics Agency awarded a $473,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services in support of Department of Defense health programs. Performance will occur at the prime contractor's facility in Conshohocken, Pennsylvania over a one day period from July 24-25,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYW4Delivery Order
The Defense Logistics Agency awarded a $1,670.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5 mL quantities. This is an unset-aside, competitively awarded contract with an ultimate completion date of July 22, 2025. The delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a leading pharmaceutical distributor, AmerisourceBergen serves as a critical federal vendor supplying medications and medical supplies to military and veteran healthcare systems. The company's Pharmaceutical Prime Vendor contract vehicle enables flexible procurement of a comprehensive range of pharmaceutical products and medical commodities to support Defense Health Agency operations and other federal healthcare beneficiaries globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/21/25 |